Major Medical Devices

Major Medical Devices, Inc. (MMD) is an emerging medical technology company based in New York, dedicated to developing innovative vascular intervention solutions. The company's flagship product, the AxSES™ system, is a next-generation aortic endograft designed for the treatment of abdominal aortic aneurysms (AAA). AxSES™ features an ultra-low-profile design and enables upper extremity access, which aims to expand patient eligibility to those with small or diseased vessels and simplify the endovascular aneurysm repair (EVAR) procedure. By eliminating the need for bilateral femoral access, the technology seeks to improve clinical outcomes, reduce procedural complexity, and enhance hospital economics in the $3 billion AAA market.